Jan Best

nl}}'' Jan Gijsbert Pieter Best (born 29 August 1941, Grou - 19 January 2023) was a Dutch pre- and protohistorian, comparative linguist, archaeologist, and author. For about 30 years, he was Professor at the University of Amsterdam, where he taught ancient history, and Mediterranean prehistory and protohistory. Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Jan Best', query time: 0.04s Refine Results
  1. 1
    Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics

    Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics by Jan Best, Lars P. Bechmann

    Published 2021-12-01
    Get full text
    Article
  2. 2
    The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis

    The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis by Joeri Lambrecht, Mustafa Porsch-Özçürümez, Jan Best, Fabian Jost-Brinkmann, Christoph Roderburg, Münevver Demir, Frank Tacke, Raphael Mohr

    Published 2021-07-01
    Get full text
    Article
  3. 3
    In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival

    In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival by Aglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, Stefan P. Mueller, Jan Best, Ken Herrmann, Peter A. Horn, Vahé Barsegian, Monika Lindemann

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?

    Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts? by Jens M Theysohn, Marcus Ruhlmann, Stefan Müller, Alexander Dechene, Jan Best, Johannes Haubold, Lale Umutlu, Guido Gerken, Andreas Bockisch, Thomas C Lauenstein

    Published 2015-01-01
    Get full text
    Article
  5. 5
    Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization

    Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Rep... by Alexander Bellendorf, Nicolai Mader, Stefan P. Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D. Pöppel, Amir Sabet

    Published 2024-01-01
    Get full text
    Article
  6. 6
    Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV

    Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV by Jan Best, Andreas Zahn, Anja Beilfuß, Svenja Sydor, Christian Fingas, Jan-Peter Sowa, Olympia Anastasiou, Vito Cicinnati, Guido Gerken, Ali Canbay, Lars P. Bechmann

    Published 2015-05-01
    Get full text
    Article
  7. 7
    Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease

    Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease by Peter Lemmer, Paul Manka, Jan Best, Alisan Kahraman, Julia Kälsch, Ramiro Vilchez-Vargas, Alexander Link, Hsin Chiang, Guido Gerken, Ali Canbay, Lars P. Bechmann, Svenja Sydor

    Published 2022-02-01
    Get full text
    Article
  8. 8
    Influence of the Bile Acid Transporter Genes <i>ABCB4</i>, <i>ABCB8</i>, and <i>ABCB11</i> and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis

    Influence of the Bile Acid Transporter Genes <i>ABCB4</i>, <i>ABCB8</i>, and <i>ABCB11</i> and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Non... by Henriette Kreimeyer, Katharina Vogt, Tobias Götze, Jan Best, Oliver Götze, Jochen Weigt, Alisan Kahraman, Mustafa Özçürümez, Julia Kälsch, Wing-Kin Syn, Svenja Sydor, Ali Canbay, Paul Manka

    Published 2023-07-01
    Get full text
    Article
  9. 9
    GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients

    GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients by Clemens Schotten, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, Claudio Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip Johnson, Heiner Wedemeyer, Jan Best

    Published 2021-07-01
    Get full text
    Article
  10. 10
    Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury

    Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury by Svenja Sydor, Paul Manka, Jan Best, Sami Jafoui, Jan-Peter Sowa, Miguel Eugenio Zoubek, Virginia Hernandez-Gea, Francisco Javier Cubero, Julia Kälsch, Diana Vetter, Maria Isabel Fiel, Yujin Hoshida, C. Billie Bian, Leonard J. Nelson, Han Moshage, Klaas Nico Faber, Andreas Paul, Hideo A. Baba, Guido Gerken, Scott L. Friedman, Ali Canbay, Lars P. Bechmann

    Published 2017-08-01
    Get full text
    Article
  11. 11
    A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver

    A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver by Paul Manka, Svenja Sydor, Julia M. Schänzer-Ocklenburg, Malte Brandenburg, Jan Best, Ramiro Vilchez-Vargas, Alexander Link, Dominik Heider, Susanne Brodesser, Anja Figge, Andreas Jähnert, Jason D. Coombes, Francisco Javier Cubero, Alisan Kahraman, Moon-Sung Kim, Julia Kälsch, Sonja Kinner, Klaas Nico Faber, Han Moshage, Guido Gerken, Wing-Kin Syn, Ali Canbay, Lars P. Bechmann

    Published 2022-01-01
    Get full text
    Article
  12. 12
    LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis

    LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis by Catherine Leyh, Niklas Heucke, Clemens Schotten, Matthias Büchter, Lars P. Bechmann, Marc Wichert, Alexander Dechêne, Ken Herrmann, Dominik Heider, Svenja Sydor, Peter Lemmer, Johannes M. Ludwig, Josef Pospiech, Jens Theysohn, Robert Damm, Christine March, Maciej Powerski, Maciej Pech, Mustafa Özcürümez, Jochen Weigt, Verena Keitel, Christian M. Lange, Hartmut Schmidt, Ali Canbay, Jan Best, Guido Gerken, Paul P. Manka

    Published 2022-09-01
    Get full text
    Article
  13. 13
    Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

    Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience by Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria A. Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N. De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Bömmel, Sabine Lieb, Sebastian Krug, Dominik Bettinger, Michael Schultheiß, Leonie S. Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito

    Published 2022-12-01
    Get full text
    Article

Search Tools: